Company Search:
Advanced Search
Sponsored Links
Tissue Regenix Group PLC Company Snapshot
Tissue Regenix Group PLC operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tissue Regenix Group PLC with three other companies in this sector in the United Kingdom: Genedrive PLC (2017 sales of £5.79 million [US$7.55 million] of which 45% was Diagnostics Segment), IXICO PLC (£4.11 million [US$5.37 million] of which 100% was Pharmaceutical), and Synairgen PLC (£5.03 million [US$6.56 million] of which 100% was Drug Discovery).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Tissue Regenix Group PLC
  Stock Performance Chart for Tissue Regenix Group PLC
  Stock Data: Recent Stock Performance:
  Current Price (4/12/2019): 6.00p
(Figures in Pounds Sterling)
1 Week -9.4%   13 Weeks -11.1%  
4 Weeks -2.8%   52 Weeks -34.1%  
Tissue Regenix Group PLC Key Data:
  Ticker: TRX Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 5,233,000
(Year Ending Jan 2018).
Employees: 79
  Currency: Pounds Sterling Market Cap: 70,303,849
  Fiscal Yr Ends: December Shares Outstanding: 1,171,730,823
  Share Type: Ordinary Closely Held Shares: 123,437,581
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.